Opinion

Yan Leyfman

Jun 17, 2025, 02:22

Yan Leyfman: Keynote Address on PD-1/PD-L1 Inhibitors at the 2025 Frontiers in Cancer Immunotherapy Symposium

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“Great Keynote address highlighting the history of PD-1/PD-L1 inhibitors at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Dr. Antoni Ribas of UCLA.”

Yan Leyfman

Antoni Ribas cancer Cancer Immunotherapy Symposium immunotherapy OncoDaily Oncology Yan Leyfman

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

OncoDaily Pulse

Aug 21, 2025, 10:23

Archana Ajmera: Meet the Experts of VIRO 2025

OncoDaily Pulse

Aug 21, 2025, 10:08

Yüksel Ürün: Meet the Experts of VIRO 2025

Voices

Aug 21, 2025, 09:46

Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 09:30

Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML

Insight

Aug 21, 2025, 09:02

Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients

Celebrities

Aug 21, 2025, 08:40

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Insight

Aug 21, 2025, 08:17

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Science

Aug 21, 2025, 06:29

Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML

Insight

Aug 21, 2025, 00:36

Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer

Voices

Aug 21, 2025, 00:00

Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway

Voices

Aug 20, 2025, 23:11

Anne Susanty: Sharing the Stage with Guillermo Chantada at SIOP 2024

Career Updates

Aug 20, 2025, 22:08

Devon J Shedlock Named Vice President and Head of Oncology Cell Therapy Technology at Genentech

Opinion

OncoDaily

Opinion

Yan Leyfman: Keynote Address on PD-1/PD-L1 Inhibitors at the 2025 Frontiers in Cancer Immunotherapy Symposium

“Great Keynote address highlighting the history of PD-1/PD-L1 inhibitors at the 2025 The New York Academy of Sciences Frontiers in Cancer Immunotherapy Symposium by Dr. Antoni Ribas of UCLA.”